MEDICAL PROPERTIES TRUST INC (MPT) Fundamental Analysis & Valuation

NYSE:MPT • US58463J3041

5.47 USD
-0.03 (-0.55%)
At close: Mar 6, 2026
5.4695 USD
0 (-0.01%)
After Hours: 3/6/2026, 4:35:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

MPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. There are concerns on the financial health of MPT while its profitability can be described as average. MPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. MPT Profitability Analysis

1.1 Basic Checks

  • In the past year MPT has reported negative net income.
  • MPT had a positive operating cash flow in the past year.
  • In multiple years MPT reported negative net income over the last 5 years.
  • MPT had a positive operating cash flow in 4 of the past 5 years.
MPT Yearly Net Income VS EBIT VS OCF VS FCFMPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • MPT's Return On Assets of -4.74% is on the low side compared to the rest of the industry. MPT is outperformed by 81.15% of its industry peers.
  • MPT's Return On Equity of -15.19% is on the low side compared to the rest of the industry. MPT is outperformed by 78.69% of its industry peers.
  • MPT has a Return On Invested Capital (2.76%) which is in line with its industry peers.
  • MPT had an Average Return On Invested Capital over the past 3 years of 1.86%. This is in line with the industry average of 3.10%.
  • The last Return On Invested Capital (2.76%) for MPT is above the 3 year average (1.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROIC 2.76%
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
MPT Yearly ROA, ROE, ROICMPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • MPT has a Operating Margin of 53.48%. This is amongst the best in the industry. MPT outperforms 95.90% of its industry peers.
  • MPT's Operating Margin has declined in the last couple of years.
  • MPT's Gross Margin of 96.07% is amongst the best of the industry. MPT outperforms 96.72% of its industry peers.
  • MPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 53.48%
PM (TTM) N/A
GM 96.07%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.46%
MPT Yearly Profit, Operating, Gross MarginsMPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MPT Health Analysis

2.1 Basic Checks

  • MPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MPT has less shares outstanding
  • Compared to 5 years ago, MPT has more shares outstanding
  • Compared to 1 year ago, MPT has a worse debt to assets ratio.
MPT Yearly Shares OutstandingMPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
MPT Yearly Total Debt VS Total AssetsMPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • MPT has an Altman-Z score of 0.03. This is a bad value and indicates that MPT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.03, MPT is doing worse than 74.59% of the companies in the same industry.
  • MPT has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
  • MPT's Debt to Equity ratio of 2.06 is on the low side compared to the rest of the industry. MPT is outperformed by 70.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Altman-Z 0.03
ROIC/WACC0.45
WACC6.07%
MPT Yearly LT Debt VS Equity VS FCFMPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 2.00 indicates that MPT should not have too much problems paying its short term obligations.
  • MPT's Current ratio of 2.00 is amongst the best of the industry. MPT outperforms 89.34% of its industry peers.
  • MPT has a Quick Ratio of 2.00. This is a normal value and indicates that MPT is financially healthy and should not expect problems in meeting its short term obligations.
  • MPT has a Quick ratio of 2.00. This is amongst the best in the industry. MPT outperforms 89.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
MPT Yearly Current Assets VS Current LiabilitesMPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MPT Growth Analysis

3.1 Past

  • MPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.39%, which is quite impressive.
  • Looking at the last year, MPT shows a decrease in Revenue. The Revenue has decreased by -2.36% in the last year.
  • Measured over the past years, MPT shows a decrease in Revenue. The Revenue has been decreasing by -4.89% on average per year.
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%

3.2 Future

  • MPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.77% yearly.
  • Based on estimates for the next years, MPT will show a small growth in Revenue. The Revenue will grow by 3.56% on average per year.
EPS Next Y137.88%
EPS Next 2Y62.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.11%
Revenue Next 2Y7.08%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MPT Yearly Revenue VS EstimatesMPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPT Yearly EPS VS EstimatesMPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

3

4. MPT Valuation Analysis

4.1 Price/Earnings Ratio

  • MPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 51.58, the valuation of MPT can be described as expensive.
  • Based on the Price/Forward Earnings ratio, MPT is valued a bit cheaper than the industry average as 63.11% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.79. MPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 51.58
MPT Price Earnings VS Forward Price EarningsMPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.3
MPT Per share dataMPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • MPT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MPT's earnings are expected to grow with 62.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.77%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. MPT Dividend Analysis

5.1 Amount

  • MPT has a Yearly Dividend Yield of 6.20%, which is a nice return.
  • MPT's Dividend Yield is a higher than the industry average which is at 7.04.
  • MPT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.2%

5.2 History

  • The dividend of MPT decreases each year by -10.38%.
  • MPT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-10.38%
Div Incr YearsN/A
Div Non Decr YearsN/A
MPT Yearly Dividends per shareMPT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of MPT are negative and hence is the payout ratio. MPT will probably not be able to sustain this dividend level.
DP-27.26%
EPS Next 2Y62.77%
EPS Next 3YN/A
MPT Yearly Income VS Free CF VS DividendMPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

MPT Fundamentals: All Metrics, Ratios and Statistics

MEDICAL PROPERTIES TRUST INC

NYSE:MPT (3/6/2026, 4:35:20 PM)

After market: 5.4695 0 (-0.01%)

5.47

-0.03 (-0.55%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners57.85%
Inst Owner ChangeN/A
Ins Owners17.26%
Ins Owner ChangeN/A
Market Cap3.29B
Revenue(TTM)972.02M
Net Income(TTM)-707.95M
Analysts51.76
Price Target5.83 (6.58%)
Short Float %27.92%
Short Ratio24.24
Dividend
Industry RankSector Rank
Dividend Yield 6.2%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-27.26%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-873.24%
Min EPS beat(2)-1816.17%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3643.79%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-2173.83%
EPS beat(12)2
Avg EPS beat(12)-1482.28%
EPS beat(16)6
Avg EPS beat(16)-1094.33%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.7%
Max Revenue beat(2)2.15%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)5.51%
Revenue beat(8)4
Avg Revenue beat(8)-17.59%
Revenue beat(12)5
Avg Revenue beat(12)-12.87%
Revenue beat(16)6
Avg Revenue beat(16)-10.4%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.58
P/S 3.52
P/FCF N/A
P/OCF 22.32
P/B 0.71
P/tB 0.71
EV/EBITDA 16.3
EPS(TTM)-0.28
EYN/A
EPS(NY)0.11
Fwd EY1.94%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.25
OCFY4.48%
SpS1.55
BVpS7.75
TBVpS7.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROCE 3.49%
ROIC 2.76%
ROICexc 2.84%
ROICexgc 2.95%
OM 53.48%
PM (TTM) N/A
GM 96.07%
FCFM N/A
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
ROICexc(3y)1.91%
ROICexc(5y)2.85%
ROICexgc(3y)1.99%
ROICexgc(5y)2.93%
ROCE(3y)2.35%
ROCE(5y)3.52%
ROICexgc growth 3Y-9.68%
ROICexgc growth 5Y-5.3%
ROICexc growth 3Y-10.05%
ROICexc growth 5Y-5.79%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.46%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Debt/EBITDA 12.51
Cap/Depr 69.46%
Cap/Sales 20.04%
Interest Coverage 1.08
Cash Conversion 19.18%
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 0.03
F-Score5
WACC6.07%
ROIC/WACC0.45
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
EPS Next Y137.88%
EPS Next 2Y62.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%
Revenue Next Year7.11%
Revenue Next 2Y7.08%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%
EBIT growth 1Y1889.1%
EBIT growth 3Y-18.68%
EBIT growth 5Y-8.21%
EBIT Next Year70.74%
EBIT Next 3Y20.45%
EBIT Next 5Y13.18%
FCF growth 1Y-139.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.55%
OCF growth 3YN/A
OCF growth 5YN/A

MEDICAL PROPERTIES TRUST INC / MPT FAQ

What is the ChartMill fundamental rating of MEDICAL PROPERTIES TRUST INC (MPT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MPT.


Can you provide the valuation status for MEDICAL PROPERTIES TRUST INC?

ChartMill assigns a valuation rating of 3 / 10 to MEDICAL PROPERTIES TRUST INC (MPT). This can be considered as Overvalued.


Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?

MEDICAL PROPERTIES TRUST INC (MPT) has a profitability rating of 4 / 10.


Can you provide the financial health for MPT stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPT) is 3 / 10.


How sustainable is the dividend of MEDICAL PROPERTIES TRUST INC (MPT) stock?

The dividend rating of MEDICAL PROPERTIES TRUST INC (MPT) is 4 / 10 and the dividend payout ratio is -27.26%.